MBX Biosciences, Inc. Liquidation Value
MBX
Other
Cash & Equivalents
$75.29M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $75.29M
Total Obligations: -$16.09M
$59.20M
Per share: $1.32
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $75.29M
AR: $0
Total Obligations: -$16.09M
$59.20M
Per share: $1.32
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $75.29M
AR: $0
Inventory: $0
Total Obligations: -$16.09M
$59.20M
Per share: $1.32
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $59.20M | $1.32 |
| Liquid Liquidation Value | $59.20M | $1.32 |
| Operating Liquidation Value | $59.20M | $1.32 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $75.29M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $15.49M |
| Long-term Debt | N/A |
| Op. Lease Liability | $596,000 |
| Finance Lease | N/A |
| Shares Outstanding | 44.9M |
Explore all 153 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $75.29M | N/A | N/A | $2.98M | $15.49M | N/A | $596,000 | N/A |
| 2025-09-30 | $223.12M | N/A | N/A | $3.77M | $12.06M | N/A | $623,000 | N/A |
| 2025-06-30 | $39.78M | N/A | N/A | $5.76M | $11.76M | N/A | $650,000 | N/A |
| 2025-03-31 | $29.90M | N/A | N/A | $4.25M | $10.48M | N/A | $130,000 | N/A |
| 2024-12-31 | $49.35M | N/A | N/A | $5.33M | $11.05M | N/A | $171,000 | N/A |
| 2024-09-30 | $132.87M | N/A | N/A | $5.00M | $10.92M | N/A | $210,000 | N/A |
| 2024-06-30 | $12.50M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-03-31 | $35.42M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes